Patent Oppositions in peptide drugs industry

Explore the competitive field of peptide drugs where companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top companies filing and facing patent oppositions, and the most recent patents under dispute. Stay informed on patent activity in peptide drugs technology and learn how to protect your intellectual property.

Get Patent Opposition Report for peptide drugs

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Report

Explore the top companies that have filed the most patent oppositions in the technology industry.

Explore the top companies that have faced the most patent oppositions in the technology industry.

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the peptide drugs industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the peptide drugs industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Last updated on: Oct 2, 2025
Patent NumberTitleApplicantOpposition DateOpposition Name

Get alerts on new patent oppositions in the peptide drugs industry

Use Of Long-Acting Glp-1 PeptidesNOVO NORDISKAug 27, 2025DR REDDYS LABORATORIES
Method For Preventing Or Treating Osteoporosis Characterized By Administering Teriparatide Or Salt Thereof Twice A WeekASAHI KASEI PHARMAAug 27, 2025GENERICS UK
A Stable Liquid Formulation Of Fusion Protein With Igg Fc DomainALTEOGENAug 25, 2025DORRIES
A Stable Liquid Formulation Of Fusion Protein With Igg Fc DomainALTEOGENAug 25, 2025DORRIES
High Dose And Low Volume Botulinum Toxin Treatment Of Facial WrinklesMERZ PHARMAAug 20, 2025IPSEN BIOPHARMA
Use Of Long-Acting Glp-1 PeptidesNOVO NORDISKAug 10, 2025ADALVO
Use Of Long-Acting Glp-1 PeptidesNOVO NORDISKAug 7, 2025GENERICS UK
Use Of Long-Acting Glp-1 PeptidesNOVO NORDISKAug 6, 2025WUESTHOFF & WUESTHOFF
A Stable Liquid Formulation Of Fusion Protein With Igg Fc DomainALTEOGENJul 18, 2025STORZ
A Stable Liquid Formulation Of Fusion Protein With Igg Fc DomainALTEOGENJul 18, 2025STORZ

To stay ahead in the competitive peptide drugs industry, companies are constantly innovating. Here are the top patents facing oppositions in the peptide drugs industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Last updated on: Oct 2, 2025
Patent NumberGrant DateTitleApplicantTotal Oppositions
Nov 21, 2018Formulation Of Boronic Acid CompoundsTHE UNITED STATES OF AMERICA11
Feb 7, 2024Glp-1 Compositions And Uses ThereofNOVO NORDISK8
Dec 11, 2019Methods Of Treating Hepatic EncephalopathySALIX PHARMACEUTICALS8
Aug 10, 2022Semaglutide In Cardiovascular ConditionsNOVO NORDISK8
Feb 7, 2024Methods For Treating Severe Atopic Dermatitis By Administering An Il-4R InhibitorSANOFI BIOTECHNOLOGY7
Sep 13, 2023Compositions Comprising A Delivery Agent And Preparation ThereofNOVO NORDISK7
Nov 3, 2021SyringeNOVARTIS7
Aug 7, 2019Methods To Mobilize Progenitor/Stem CellsGENZYME7
Apr 14, 2021Tablet Formulation Comprising A Peptide And A Delivery AgentNOVO NORDISK7
Aug 2, 2023Gip/Glp1 Agonist CompositionsELI LILLY7